128 related articles for article (PubMed ID: 36846888)
21. Costs of the use of carbetocin in the prevention of uterine atony following delivery of the infant by Caesarean section - retrospective multicenter study.
Sobkowski M; Celewicz Z; Kalinka J; Szymanowski K; Serafin M; Śmieja K; Grzymała-Figura A; Pacocha K; Pieniążek I; Walczak J; Żyła A; Bierut A
Ginekol Pol; 2016; 87(9):621-628. PubMed ID: 27723068
[TBL] [Abstract][Full Text] [Related]
22. The minimum effective dose (ED
Tyagi A; Nigam C; Malhotra RK; Bodh P; Deep S; Singla A
Int J Obstet Anesth; 2024 Feb; 57():103962. PubMed ID: 38103940
[TBL] [Abstract][Full Text] [Related]
23. A study protocol for the cardiac effects of a single dose of either oxytocin 2.5 IU or carbetocin 100 µg after caesarean delivery: a prospective randomized controlled multi-centre trial in Norway.
Bekkenes M; Jørgensen MM; Flem Jacobsen A; Wang Fagerland M; Rakstad-Larsen H; Solberg OG; Aaberge L; Klingenberg O; Steinsvik T; Rosseland LA
F1000Res; 2021; 10():973. PubMed ID: 34745566
[No Abstract] [Full Text] [Related]
24. Prophylactic Dose of Oxytocin for Uterine Atony during Caesarean Delivery: A Systematic Review.
Baliuliene V; Vitartaite M; Rimaitis K
Int J Environ Res Public Health; 2021 May; 18(9):. PubMed ID: 34068723
[TBL] [Abstract][Full Text] [Related]
25. Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes.
Lee AI; Wong CA; Healy L; Toledo P
Int J Obstet Anesth; 2014 Feb; 23(1):18-22. PubMed ID: 24332518
[TBL] [Abstract][Full Text] [Related]
26. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
[TBL] [Abstract][Full Text] [Related]
27. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
Rath W
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery.
Wetta LA; Szychowski JM; Seals S; Mancuso MS; Biggio JR; Tita AT
Am J Obstet Gynecol; 2013 Jul; 209(1):51.e1-6. PubMed ID: 23507549
[TBL] [Abstract][Full Text] [Related]
29. Development of clinical risk-prediction models for uterine atony following vaginal and cesarean delivery.
Ende HB; French B; Shi Y; Kertai MD; Osmundson SS; Bauchat JR
Int J Obstet Anesth; 2022 Aug; 51():103550. PubMed ID: 35550835
[TBL] [Abstract][Full Text] [Related]
30. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
[TBL] [Abstract][Full Text] [Related]
31. Refractory uterine atony: still a problem after all these years.
Balki M; Wong CA
Int J Obstet Anesth; 2021 Nov; 48():103207. PubMed ID: 34391025
[TBL] [Abstract][Full Text] [Related]
32. [Carbetocin and oxytocin: Prevention of postpartum hemorrhage in patients with risk factors for uterine atony].
Carrillo-Gaucín S; Torres-Gómez LG
Rev Med Inst Mex Seguro Soc; 2016; 54 Suppl 3():S284-S290. PubMed ID: 27855051
[TBL] [Abstract][Full Text] [Related]
33. Systematic review of oxytocin dosing at caesarean section.
Stephens LC; Bruessel T
Anaesth Intensive Care; 2012 Mar; 40(2):247-52. PubMed ID: 22417018
[TBL] [Abstract][Full Text] [Related]
34. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
Chaudhuri P; Banerjee GB; Mandal A
Int J Gynaecol Obstet; 2010 Apr; 109(1):25-9. PubMed ID: 20070961
[TBL] [Abstract][Full Text] [Related]
35. [Oxytocin for the prophylaxis of uterine atony after cesarean delivery. Should we reconsider our protocols?].
Schiraldi R; Guasch E
Rev Esp Anestesiol Reanim; 2014; 61(7):359-61. PubMed ID: 24924341
[No Abstract] [Full Text] [Related]
36. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section.
Sartain JB; Barry JJ; Howat PW; McCormack DI; Bryant M
Br J Anaesth; 2008 Dec; 101(6):822-6. PubMed ID: 18845650
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Br J Anaesth; 2017 May; 118(5):772-780. PubMed ID: 28498927
[TBL] [Abstract][Full Text] [Related]
38. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
[TBL] [Abstract][Full Text] [Related]
39. Oxytocin infusion rates for maintaining uterine tone during non-elective cesarean section in laboring patients: a randomized, controlled trial.
Mohta M; Siddiqui S; Chilkoti GT; Agarwal R
J Anesth; 2022 Aug; 36(4):456-463. PubMed ID: 35484429
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the benefits and hemodynamic side effects of oxytocin between intravenous infusion with and without bolus injection during caesarean section.
Miyoshi Y; Kaneko S; Suga S; Koga M; Sugimi S; Yamashita H; Yamaguchi M; Yasuhi I
J Obstet Gynaecol; 2021 May; 41(4):557-561. PubMed ID: 32729350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
